Thomas Foster

Dr. Thomas Foster is a postdoctoral research associate within the Division of Cardiovascular Medicine at the Radcliffe Department of Medicine, University of Oxford. He completed both his undergraduate and postgraduate studies at Curtin University, in Perth, Western Australia. He received his PhD in Biomedical Science, working on the development of polymeric nanoparticle delivery systems for gene therapies in neurosensory disease.  

In his current position at The University of Oxford, he is working on the development and optimisation of graphene nanomaterials for the delivery of nitric oxide in cardiovascular disease. This work involves interdisciplinary collaboration across cell biology, biochemistry, and biomaterials to optimise nanoparticle formulations and evaluate their efficacy.

Thomas has a keen interest in all aspects of delivery science and nanotechnology. He has published widely on this topic, including in the delivery of cell therapies for diabetes, gene therapies for vision impairment, small molecules for hearing loss, and other therapeutics. He is also particularly engaged with commercialisation and clinical translation of therapeutics.